---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-046817"
form_type: "8-K"
ticker: "DMRA"
cik: "0001800315"
company_name: "Damora Therapeutics, Inc."
filed_at: "2026-02-11T23:59:59+00:00"
generated_at: "2026-05-16T03:21:04.377502+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Galecto raises $295.9M in equity offering; funds Phase 3 of DMR-001

## Summary
- Offering of 14,473,685 shares at $19.00 each; underwriters' option for 2,171,052 additional shares exercised in full.
- Net proceeds of approximately $295.9M after underwriting discounts and expenses.
- Proceeds intended to fund operations into Phase 3 development of DMR-001.
- Underwriting agreement with Jefferies LLC and Leerink Partners LLC; closing expected February 12, 2026.
- Offering was made under an automatic shelf registration statement on Form S-3 (File No. 333-293343).

## SEC filing metadata
- accession: 0001193125-26-046817
- form_type: 8-K
- ticker: DMRA
- cik: 0001800315
- company_name: Damora Therapeutics, Inc.
- filed_at: 2026-02-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1800315/000119312526046817/0001193125-26-046817-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1800315/000119312526046817/d38009d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-046817
- JSON: https://secwatch.observer/filing/0001193125-26-046817.json
- Plain text: https://secwatch.observer/filing/0001193125-26-046817.txt

## Key facts
- Material Agreements
  Damora Therapeutics, Inc. entered into Underwriting Agreement with Jefferies LLC and Leerink Partners LLC, as the representatives of the several underwriters named therein valued at approximately $295.9 million (effective 2026-02-10).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Jefferies LLC and Leerink Partners LLC, as the representatives of the several underwriters named therein
  - Value: approximately $295.9 million
  - Effective: 2026-02-10
  source text: On February 10, 2026, Galecto, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Jefferies LLC and Leerink Partners LLC, as the representatives of the several underwriters named therein (the “Underwriters”), relating to the offer and sale (the “Offering”) of 14,473,685 shares of the Company’s common stock, par value $0.00001 per share (the “Common Stock”), at a public offering price of $19.00 per share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1800315/000119312526046817/0001193125-26-046817-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.